RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 13 analysts with an average price target of $231.13. This is a potential upside of $14.69 (6.79%) from yesterday's end of day stock price of $216.44.

ResMed's activity chart (see below) currently has 91 price targets and 121 ratings on display. The stock rating distribution of RMD is 67.24% BUY, 31.03% HOLD and 1.72% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.87% with an average time for these price targets to be met of 102.82 days.

Highest price target for RMD is $286, Lowest price target is $219, average price target is $244.88.

Most recent stock forecast was given by MIKE MATSON from NEEDHAM on 31-Jan-2025.

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Currently out of the existing stock ratings of RMD, 39 are a BUY (67.24%), 18 are a HOLD (31.03%), 1 are a SELL (1.72%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2 months 9 days ago
(31-Jan-2025)

11/11 (100%)

$-7.67 (-3.15%)

212

Buy

$286

$80.83 (39.40%)

2 months 9 days ago
(31-Jan-2025)

14/17 (82.35%)

$50.35 (21.37%)

310

Hold

$260

$54.83 (26.72%)

$252

2 months 9 days ago
(31-Jan-2025)

1/2 (50%)

$24.35 (10.33%)

17

Hold

$250

$44.83 (21.85%)

$225

5 months 15 days ago
(25-Oct-2024)

5/5 (100%)

$-4.95 (-1.94%)

30

Buy

$250

$44.83 (21.85%)

$215

6 months 10 days ago
(30-Sep-2024)

11/11 (100%)

$6.95 (2.86%)

115

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RMD (ResMed) average time for price targets to be met?

On average it took 102.82 days on average for the stock forecasts to be realized with a an average price target met ratio 61.87

Which analyst has the current highest performing score on RMD (ResMed) with a proven track record?

LYANNE HARRISON

Which analyst has the most public recommendations on RMD (ResMed)?

Lyanne Harrison works at BAML and has 17 price targets and 9 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

David Low with highest potential upside - $80.83

Which analyst is the currently most reserved on RMD (ResMed)?

Matt O'brien with lowest potential downside - -$87.2

ResMed in the News

Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?

ResMed RMD shares rallied 3.8% in the last trading session to close at $213. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock’s 11.7% loss over the past four weeks. ResMed scored a strong price increase, on investors’...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?